Picture of BCAL Diagnostics logo

BDX BCAL Diagnostics News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Bcal Diagnostics Appoints Anne-Louise Arnett As CEO

May 11 (Reuters) - BCAL Diagnostics Ltd BDX.AX:

BCAL APPOINTS ANNE-LOUISE ARNETT AS CHIEF EXECUTIVE OFFICER

APPOINTS ANNE-LOUISE ARNETT AS CEO EFFECTIVE JUNE 1, 2026

Further company coverage: BDX.AX

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on BCAL Diagnostics

See all news